Delivery Order 140D0420D0003-140D0422F0336
- Not listed
- The Environmental Protection Agency awarded a $1.756 million firm fixed price delivery order contract to Cyprotex US LLC under the agency's HIGH THROUGHPUT TOXICOKINETICS program. The contract calls for Cyprotex to provide toxicokinetics services to the EPA from its location in Watertown, Massachusetts over an 11-month period ending in May 2021. As a leading provider of in vitro toxicology and ADMET screening assays, Cyprotex will leverage its expertise to support the EPA's work evaluating the...
- This is a firm-fixed-price delivery order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $451,818.00 contract supports the EPA's High Throughput Toxicokinetics (HTTK) program, under which Cyprotex will provide high-throughput toxicokinetics testing services using in vitro assays. This work helps the EPA rapidly and cost-effectively generate toxicokinetic data on...
- This is a firm fixed price delivery order contract awarded by the Environmental Protection Agency (EPA) Office of Chemical Safety and Pollution Prevention to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $939,950.00 contract is for specialized toxicology services, including steroidogenesis assays and multiplexed endpoint sample analysis, to be performed at Cyprotex's facility in Watertown, Massachusetts. The contract is not set aside and is part of a...
- This is a firm-fixed-price delivery order awarded by the U.S. Environmental Protection Agency (EPA) to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $362,208.00 contract supports the EPA's High Throughput Toxicokinetics (HTTK) program, enabling the agency to rapidly and cost-effectively generate toxicokinetic data on industrial chemicals and environmental contaminants. The contract provides specialized testing services to assess the potential human health and...
- This is a delivery order contract awarded by the U.S. Environmental Protection Agency (EPA) to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $44,744 firm-fixed-price contract is for toxicokinetic testing services to support the EPA's High Throughput Toxicokinetics (HTTK) program, which aims to rapidly and cost-effectively generate toxicokinetic data on industrial chemicals and environmental contaminants. This contract is part of a larger $13 million...
- This is a firm-fixed-price delivery order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $203,550.00 contract is to provide high-throughput complex cell co-culture systems to support the EPA's toxicokinetics research program. This work involves rapidly generating absorption, distribution, metabolism, and excretion (ADME) data on hundreds of chemical compounds...
- This is a firm-fixed-price delivery order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The $169,950.00 contract is for a plasma binding assay under task order 7 of the CYPROTEX EPD11082 contract. Cyprotex specializes in predictive toxicology, absorption, distribution, metabolism, and excretion (ADME) research, and in vitro toxicology services. This work supports the...
- This is a $50,000.00 firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The contract is for testing of chemical compounds in a human neurite outgrowth assay as part of absorption, distribution, metabolism, and excretion (ADME) and toxicology (ADME-TOX) services. Cyprotex has significant expertise in predictive toxicology, ADME research, and in...
- This is a firm-fixed-price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned for-profit contract research organization. The $49,999.98 award is to conduct testing on chemicals using a network formation assay, supporting the EPA's chemical risk assessment efforts. Cyprotex specializes in predictive toxicology, absorption, distribution, metabolism, and excretion (ADME) research, and in vitro...
- This firm-fixed-price Delivery Order contract, valued at $218,344.00, was awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Cyprotex US LLC, a foreign-owned, for-profit contract research organization. The contract is for the provision of a STEROIDOGENESIS ASSAY (ASSAY AND MULTIPLEXED ENDPOINT SAMPLE ANALYSIS) service, with an ultimate completion date of August 8, 2017. The contract has no set-aside designation. Cyprotex US LLC is a specialist in...
- 140D0420D0003Indefinite Delivery Contract
- 140D0420D0003-140D0422F0336Delivery Order
Cyprotex US LLC has been awarded a firm fixed price delivery order against its indefinite delivery indefinite quantity contract with the Environmental Protection Agency (EPA) to provide toxicokinetic testing services. The $133,690 order calls for Cyprotex to conduct toxicokinetic testing out of its Watertown, Massachusetts facility in support of the EPA Office of Research and Development's chemical risk assessment efforts. Through high-throughput in vitro assays on hundreds of industrial chemicals and contaminants, Cyprotex will generate data to aid EPA scientists in evaluating potential human health and environmental impacts over the one year period of performance ending in April 2023. No set-aside provision was applied to this order placed under Cyprotex's single-award IDIQ, which has yielded over $3.5 million in task orders to date in support of the EPA's research objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $133.7k | 4/20/22 |